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Hypertension aﬀects approximately 1 billion individuals worldwide. Pharmacological therapy has not been perfected and often
is associated with adverse side eﬀects. Acupuncture is used as an adjunctive treatment for a number of cardiovascular diseases
like hypertension. It has long been established that the two major contributors to systemic hypertension are the intrarenal renin-
angiotensin system and chronic activation of the sympathetic nervous system. Recent evidence indicates that in some models of
cardiovascular disease, blockade of AT1 receptors in the rostral ventrolateral medulla (rVLM) reduces sympathetic nerve activity
and blood pressure, suggesting that overactivity of the angiotensin system in this nucleus may play a role in the maintenance
of hypertension. Our experimental studies have shown that electroacupuncture stimulation activates neurons in the arcuate
nucleus, ventrolateral gray, and nucleus raphe to inhibit the neural activity in the rVLM in a model of visceral reﬂex stimulation-
induced hypertension. This paper will discuss current knowledge of the eﬀects of acupuncture on central nervous system and
how they contribute to regulation of acupuncture on the endocrine system to provide a perspective on the future of treatment of
hypertension with this ancient technique.
1.Introduction
Hypertension aﬀects approximately 1 billion individuals
worldwide [1]. Hypertension is the most common chronic
disorder in the United States, aﬀecting 29% of the adult
population [1]. The prevalence of this disorder increases
with age; for normotensive middle-aged adults in the US,
the lifetime risk of developing hypertension approaches 90%
[2]. Although a number of treatment strategies have been
developed for this disease, treatment has not been perfected
and often is associated with adverse side eﬀects.
Hypertension is the ﬁnal outcome of a complex inter-
action between genetic and environment factors that act on
physiological systems involved in blood pressure (BP) regu-
lation (i.e., those that inﬂuence intravascular ﬂuid volume,
myocardial contractility and vascular tone) [3]. Evidence
suggests that increased sympathetic neural activity plays a
role in causing hypertension in some subjects who have a
genetic tendency toward increased sympathetic activity as
a result of repetitive psychogenic stress, obesity, or high sodi-
um intake [3]. An important hypothesis in the pathogenesis
of essential hypertension involves an interaction between
high dietary sodium intake and defects in renal sodium
excretion, which can be inﬂuenced by sympathetic neu-
ral activity and the renin-angiotensin-aldosterone system
[3]. Enhanced sympathetic activity increases the secretion
of renin and angiotensin. Angiotensin II enhances renal
tubular sodium reabsorption directly and indirectly through
increased release of aldosterone.
Acupuncture increasingly is being accepted as an alterna-
tive medical therapy in the United States. Manual acupunc-
ture and its potent alternative, electroacupuncture (EA),
have been used in Asia to treat a number of cardiovascular
diseases including hypertension. Many Western physicians,
however, are reluctant to recommend acupuncture, because
its action in the treatment of hypertension remains contro-
versial and because the physiological mechanisms determin-
ing its actions are largely unknown. This paper will discuss2 Evidence-Based Complementary and Alternative Medicine
current knowledge of the eﬀects of acupuncture on central
nervous system and how they contribute to regulation by
acupunctureoftheendocrinesystemtoprovideaperspective
on the future of treatment of hypertension with this ancient
technique.
2.ClinicalStudy ofAcupuncturein
Treatment of Hypertension
In the past three decades, there have been a number of
clinical studies focused on the eﬀectiveness of acupuncture
at speciﬁc acupoints to reduce BP in essential hypertension.
As early as the 1950s, publications in China reported that
acupuncture eﬀectively reduced BP in hypertensive patients
[4, 5]. In 1975, Tam found that acupuncture produced a
signiﬁcant reduction in systolic and diastolic BP in 24 out
of 28 patients with essential hypertension [6]. Figure 1 shows
a number of acupoints found to be eﬀective in reducing BP,
includingpericardium5,6(P5,6),stomach36(ST36),large
intestine 4, 11 (LI 4, 11), bladder 18, 20 (BL 18, 20), and
gallbladder 34 (GB 34) [7, 8].
3.AcupointsSelection
We have evaluated the point speciﬁcity in EA treatment
of reﬂex-induced hypertension caused by the gallbladder
or splanchnic nerve (SN) stimulation in cats. This visceral
reﬂex leads to stimulation of the sympathetic nervous
system through the activation of cardiovascular premotor
sympathetic neurons in the rostral ventrolateral medulla
(rVLM). We observed that EA at P 5-6 (pericardial meridian,
overlying the median nerve) and LI 10-11 (large intestine
meridian, overlying the deep radial nerve) are most eﬀective
in reducing reﬂex-induced hypertension. EA at LI 4–L7
(large intestine and lung meridians, overlying branches of
median and the superﬁcial radial nerve) and ST 36-37
(stomach meridian overlying the deep peroneal nerve) are
less eﬀective, while EA at LI 6-7 and K1-B67 does not
inﬂuence BP. Furthermore, direct stimulation of the deep or
superﬁcialnervesunderneaththeacupointsproducessimilar
results [9, 10]. Similar observations have been made in a rat
model employing gastric distension to elevate BP [11, 12].
4.StimulationParameters
EA rather than manual acupuncture has been used in
many studies on cardiovascular related diseases, because
the parameters of EA can be precisely controlled so the
results are reproducible, whereas the outcome from manual
acupuncture is operator dependent and therefore, is not as
reproducible. A low frequency of 2Hz is used more fre-
quentlytotreathypertension,becauseEAinducesfrequency-
dependent release of neuropeptides. EA at 2Hz produces
a signiﬁcant increase in enkephalin-like immunoreactivity
but not in dynorphin immunoreactivity, whereas 100Hz
increases dynorphin immunoreactivity but not enkephalin
immunoreactivity [13]. The similar results were conﬁrmed
in humans [14]. In the brain, enkephalins and endorphins
as well as their associated δ-a n dμ-opioid receptors have
been shown to be more important in modulating the
cardiovascularactionsofEAthandynorphin(κ-opioid)[15].
In our rat model of reﬂex hypertension, sham acupunc-
ture involving needle insertion without manipulation at
P 5-6 or LI 6-7 acupoints did not attenuate the gastric
distention-induced hypertension, thus demonstrating that
this procedure can serve as a control for EA. However,
EA at P 5-6, H 6-7 (overlying the ulnar nerve) or ST 36-
37 with low current (2mA) and low frequency (2Hz) for
30min inhibited the reﬂex-induced hypertension. Increasing
the stimulation frequency to 40 or 100Hz did not inhibit
the elevated BP. In this regard, we observed a reciprocal
relationship between the frequency of stimulation and the
aﬀerent response. Thus, it appears that low-frequency, low-
current EA in a point-speciﬁc manner optimally inﬂuences
reﬂex-induced hypertension [11, 12].
5. Central Regulation of Blood Pressure
Anincreasingnumberofstudieshavedemonstratedacritical
role for the central nervous system in the development
and maintenance of hypertension. In particular, increases
in sympathetic nerve activity and alterations in arterial
baroreﬂex function appear to contribute to the pathogenesis
of this disease [16]. The development of hypertension in
various animal models of hypertension, such as the spon-
taneously hypertensive rat (SHR), the renin transgenic
(TGR mRen2) rat, the Dahl salt-sensitive rat, and the
deoxycorticosterone acetate- (DOCA-) salt rat, is associated
with increases in sympathetic activity. Increased sympathetic
nerveactivity elevatesBPthrougharteriolarconstrictionand
by increasing the force and rate of contraction of the heart to
increasecardiacoutput.Renalsympatheticnerveactivityalso
stimulates renin secretion that activates the systemic renin-
angiotensin system leading to angiotensin (Ang) II-induced
vasoconstriction and sodium retention [17]. Alteration of
arterial baroreﬂex function has also been implicated in the
development of hypertension [18] .C a r o t i ds i n u sa n da o r t i c
arch baroreceptors respond to changes in BP by modulating
parasympathetic and sympathetic outﬂow and, hence, heart
rate,cardiac output,andvasculartone.In response toa static
increase in BP, the baroreﬂex resets towards a higher pressure
[19]. In hypertensive conditions, resetting of the operational
point of the arterial baroreﬂex, therefore, contributes to
maintaining increased BP rather than opposing it. Similar
to animal models of hypertension, hypertension in human
subjects is associated with increases in sympathetic activity
and blunted arterial baroreﬂexes [3, 18, 20, 21].
In hypertensive animals, functional changes within the
central nervous system have been detected largely in hypo-
thalamic and medullary areas that modulate sympathetic
outﬂow [22]. Ang II contributes to cardiovascular regulation
via its action at various hypothalamic and medullary areas
to enhance sympathetic outﬂow, blunt the sensitivity of the
baroreﬂex, and stimulate secretion of vasopressin [23, 24].
Over the past decade, we have examined the central
neural regulation of visceral reﬂex-induced hypertension
by acupuncture in diﬀerent regions of brain, including theEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Location of acupoints along meridians. Note that although all meridians are bilateral, they are only drawn on one side for
simplicity. Abbreviations of meridians: G: gallbladder; L: lung; LI: large intestine; P: pericardium; ST: stomach; BL: bladder.
rVLM,hypothalamicarcuatenucleus,midbrainventrolateral
periaqueductalgray(vlPAG)nuclei,medullarynucleusraph´ e
pallidus (NRP), and dorsal horn and intermediolateral col-
umn of the spinal cord.
6. EAInhibition of Neural Activityin the rVLM
The rVLM plays a critical role in the regulation of BP [25].
Inhibition of neuronal function in this nucleus results in
large decreases in BP [26]. We have demonstrated previously
that both low-frequency electro- and manual acupuncture
inhibit elevated BP as well as premotor sympathetic neu-
ral ﬁring in the rVLM [12]. Administration of naloxone
(nonspeciﬁc opioid receptor antagonist) or gabazine (γ-
aminobutyric acid or GABA type A receptor blocker) in
the rVLM abolishes the EA modulation [27]. The rVLM
is an important brain stem region that processes somatic
inputs during acupuncture stimulation. Electrophysiological
studies of neuronal activity in the rVLM have shown
that as compared to cardiovascular inactive points (LI 6-
7, G 37–39), P 5-6 and certain acupoints along the large
intestine meridian (LI 4–11), located over deep somatic
neural pathways (median and deep radial nerves), provide
more aﬀerent input to cardiovascular premotor sympathetic
neurons in the rVLM [10]. This observation likely explains
why acupuncture over these deep nerves most eﬀectively
lower elevated sympathetic outﬂow and BP.
7.NeurotransmittersinrVLM,Arcuate,
andvlPAG
Early studies in several models of hypertension suggested
thatEAlowerstheelevatedBPthroughthereleaseofopioids,
GABA, nociceptin, and serotonin (or 5-hydroxytryptamine,
5-HT) in the rVLM [28–32]. More recently, we have demon-
strated that the EA inhibition of visceral reﬂex-induced
hypertension in cats is related to the activation of μ-a n d
δ-, but not κ-opioid receptors in the rVLM, suggesting that4 Evidence-Based Complementary and Alternative Medicine
endorphins, enkephalins, and perhaps endomorphin, but
not dynorphin, are mainly responsible for EA modulation of
cardiovascular responses.
Immunohistochemical staining studies have demon-
strated the presence of enkephalinergic neurons in the rVLM
and endorphinergic neurons in the arcuate nucleus that
project directly to the rVLM and that both neurotransmitter
systems are activated by EA [33]. EA inhibits the reﬂex
hypertension through opioid-mediated inhibition of gluta-
mate in the rVLM [34]. Electrophysiological studies [24]
have shown that reciprocal excitatory glutamatergic (NMDA
and non-NMDA) projections exist between the arcuate
nucleus and vlPAG that may participate in the EA inhibition
of cardiovascular function. This reciprocal projection may
include a cholinergic component in the arcuate nucleus but
n o ti nt h ev l P A G[ 35].
Furthermore, EA, through presynaptic endocannabinoid
CB1 receptor stimulation, reduces the vlPAG release of
GABA but not glutamate during EA [36]. Reduced GABA
disinhibits vlPAG neurons, thus increasing their activity,
which, in turn, through an action in the NRP inhibits
rVLM cardiovascular sympathetic neurons and related sym-
pathoexcitatory reﬂex responses [37]. It is clear, therefore,
that a variety of neurotransmitter systems underlie the car-
diovascular modulation of EA. This includes both excitatory
and inhibitory neurotransmitters, with their importance
varying between the diﬀerent nuclei.
8. Long-Loop Pathway for
EACardiovascularModulation
The role of the hypothalamic arcuate nucleus and its inter-
action with the vlPAG and rVLM in the EA-cardiovascular
sympathoexcitatory responses has been extensively studied
[10, 31, 38, 39]. Microinjection of the excitatory amino
acid DLH, into the arcuate nucleus augments the responses
of vlPAG neurons, while microinjection of small volumes
(50nL) of kainic acid (KA) causes reversible depolarization
blockade that transiently deactivates arcuate neurons and
decreases the vlPAG responses to SN stimulation [31].
Additionally, EA increases SN-evoked discharge of vlPAG
neurons, a response that can be blocked by microinjection
of KA into the arcuate nucleus. Microinjection of DLH into
the arcuate nucleus, like EA, inhibits the reﬂex increase in
BP induced by application of bradykinin to gallbladder for
approximately 30min. Finally, microinjection of KA into the
arcuate blocks the inhibitory inﬂuence of EA on the reﬂex
hypertension. As such, these results suggest that excitatory
projections from the arcuate nucleus to the vlPAG appear
to be essential to the inhibitory inﬂuence of EA on the
reﬂex increase in BP induced by SN and gallbladder aﬀerent
stimulation.
9.vlPAG-rVLMProjections
The vlPAG provides inhibitory input to premotor sympa-
thetic neurons in the rVLM to ultimately reduce sympathetic
outﬂow and reﬂex elevations in BP [39]. Direct axonal
projections from the vlPAG to the medulla have been
documented in tract tracing studies [40]. However, a vlPAG
projection to the raph´ e, in particular the nucleus raph´ e
obscurus (NRO) also exists and has been thought to form an
indirectpathwayfromthevlPAGtotherVLMthatisinvolved
in the EA-cardiovascular response [41]. Recent studies have
suggested, however, that the NRP, located more ventrally
than the NRO or the nucleus raph´ e magnus, contains more
cells activated during median nerve stimulation with EA at
the P 5-6 acupoints, as judged by the concentration of c-
Fos labeling [42]. Chemical blockade of the NRP with KA
or kenurenic acid transiently reverses activation of neurons
in the rVLM during stimulation of the vlPAG as well as
EA modulation of visceral excitatory reﬂexes [43]. Further-
more, the NRP inhibits rVLM activity, including activity
of bulbospinal premotor sympathetic neurons. Serotonin
projections fromtheraph´ eactingon5-HT1A receptorsinthe
rVLM complete the vlPAG-NRP-rVLM circuit to modulate
cardiovascular activity [43]. Thus, an indirect connection
from the vlPAG to the rVLM involving a serotonergic
connection between the NRP and the rVLM plays an impor-
tant role in the long-loop modulation of cardiovascular
sympatheticoutﬂowduringreﬂexvisceralstimulation.These
studiesdonoteliminatethepossibilitythatdirectprojections
between the vlPAG and the rVLM also might serve a
functional role in EA-cardiovascular modulation. The direct
orindirectprojectionsfromthevlPAGtotherVLMcomplete
the long-loop pathway and provide an important source for
the inhibitory inﬂuence of EA on rVLM premotor neurons
and ultimately sympathoexcitatory cardiovascular responses
[41].
10.ArcuaterVLM Projections
Asnotedpreviously,neuronsinthevlPAGreceiveconvergent
inputfromanumberofsomaticnervesstimulatedduringEA
as well as from the arcuate nucleus. Bilateral microinjection
of KA into the rostral vlPAG partially reverses rVLM
neuronal responses and cardiovascular inhibition during
DLH stimulation of the arcuate. Conversely, depolarization
blockade of the caudal vlPAG completely reverses arcu-
ate evoked rVLM responses [41]. In parallel studies, we
have observed that arcuate neurons can be antidromically
activated from the rVLM and that arcuate perikarya are
labeled with a retrograde tracer microinjected into the
rVLM [41]. Many neurons from the arcuate that project to
the rVLM are activated by EA stimulation (c-Fos positive)
and they frequently contain opioid peptides, particularly β-
endorphin [44]. As such, the vlPAG, particularly the caudal
vlPAG, appears to be required for inhibition of rVLM
neuronal activation by the ARC and subsequent EA-related
cardiovascular activation. However, direct projections from
the arcuate nucleus to the rVLM, likely serve as an important
source of β-endorphin since this projection contains this
opioid peptide [41]. This latter observation is consistent
with our earlier anatomical study showing that cells in
the rVLM contain enkephalin but not β-endorphin [44].
Hence, EA-cardiovascular responses that result from the
action of β-endorphin on μ-opioid receptors located onEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Neural circuits of acupuncture’s action on cardiovascular sympathoexcitatory visceral reﬂex elevation of blood pressure.
Abbreviations: ARC: arcuate nucleus; vlPAG: ventrolateral periaqueductal gray; NR: nuclei raphe; rVLM: rostral ventrolateral medulla.
From[38].
rVLMsympathoexcitatorypremotorneuronsdependonthis
hypothalamic-medullary projection [45].
11. Role of SpinalCord in
Acupuncture-CardiovascularResponse
The spinal cord processes somatic and visceral reﬂexes as
well as outputs from the central nervous system to eﬀector
organs involved in cardiovascular reﬂex regulation [46].
Anatomical and physiological studies indicate that the dorsal
horn of the spinal cord serves as a major center for EA-
induced analgesia [47, 48]. Both low- and high-frequency
EA at Zusanli (ST 36) acupoint increase Fos immunoreactive
neurons in the superﬁcial laminae (I and II) in the dorsal
horn of the spinal cord [48]. Since opioid or nociceptin-
like immunoreactivity is present in the spinal sympathetic
nuclei (i.e., intermediolateral column, IML) [49, 50], we
have considered the possibility that EA also inﬂuences the
neurotransmission between the brain stem and the IML
[51]. In this regard, our studies have found that both
opioid and nociceptin reduce the response to rVLM-induced
sympathoexcitation, indicating that the two peptides can
regulate sympathetic outﬂow [52, 53]. In addition, there
has been a suggestion that descending pathways from the6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Neuroendocrine modulation of blood pressure by ac-
upuncture. Abbreviations: GABA, γ-aminobutyric acid; 5HT, 5-
hydroxytryptamine or serotonin; NO: nitric oxide; IML: interme-
diolateral column of the spinal cord.
brain stem (presumably to the dorsal horn of the spinal
cord) may inﬂuence the segmental processing of somatic
inputsduringEA[54,55].Aﬀerentstimulationcanmodulate
sympathetic activity through the inhibition of excitatory
interneurons [56]. Furthermore, somatic stimulation can
elicit excitatory and inhibitory responses in both IML and
dorsal horn interneurons, depending on the dermatome
stimulated [57]. These interneurons appear to form impor-
tant links in the spinal cord circuitry involved in autonomic
control [58]. Taken together, these results indicate that
opioid and nociceptin play a role in the processing of spinal
cord interneuron activity in the EA response. However,
spinal circuits controlling the cardiovascular visceral reﬂex
responses during EA require further elucidation.
12. Endocrineand VascularActions
of Acupuncture
Acupuncture reduces BP through modulation of the en-
docrine system, including decreases in plasma renin, aldos-
terone, and angiotensin II activity [59–61], and increased
excretion of sodium [62]. Also, plasma norepinephrine,
serotonin, and endorphin levels are reduced by acupuncture,
reﬂecting its ability to modulate the neurohumoral system
[63]. A laboratory-based study has demonstrated that long-
term treatment with EA delayed hypertension development
and restored nitric oxide in the plasma of SHRs [64].
Endothelial neuronal nitric oxide synthase (NOS) expres-
sion was signiﬁcantly increased by EA in the mesenteric
artery of SHRs, whereas neuronal (nNOS) expression was
signiﬁcantly attenuated. Additionally, EA at ST 36 induced
nNOS expression in the gracile nucleus and medial nucleus
tractus solitaries, and increased nNOS in the nuclei may
modify central cardiovascular regulation, which contributes
to hypotensive eﬀects of acupuncture [65].
13. Short-Term and Long-LastingEffect
of Acupuncture
Williams and colleagues found that EA induced a signiﬁcant
and immediate poststimulation short-term reduction of
diastolic blood pressure [66]. In 1997, a small study of
50 patients with essential hypertension found that shortly
after 30 minutes of acupuncture both systolic and diastolic
BP were lowered by 10–20mmHg [61]. These data suggest
that there is an immediate postacupuncture phenomenon.
Our experimental studies in anesthetized animals have
shown that the inhibitory eﬀect of acupuncture on BP
reﬂex responses occurs after 10–20min of the start of EA
stimulation and can last for as much as 60–90min after
termination of EA. In addition, in a preliminary study
utilizing 24hr ambulatory blood pressure monitoring [67],
we have observed that 8 week of acupuncture lowers BP of
hypertensive patients with mild-to-moderate hypertension
(BP 140–180/90–110mmHg) by 12–18mmHg. This eﬀect
lasts for 4 weeks after termination of EA. These data suggest
that EA at select acupoints (P5-P6 and ST 36-ST 37) known
to have strong cardiovascular actions, performed once
weeklyfor8weeks,signiﬁcantlyreducesBP.Importantly,this
beneﬁcial eﬀect appears to persist for a prolonged period of
time.
Several mechanisms might be involved in the long-
lasting inhibitory action of acupuncture in hypertension.
For example, the modulation by EA of rVLM sympathetic
premotorneuronalresponsestoreﬂex-inducedhypertension
lasts for 30–40min after the cessation of EA as a result of
opioid and GABA modulation in this medullary region [68].
A recent study from our laboratory shows that reciprocal
excitatory projections between the arcuate nucleus and the
vlPAGmayformareinforcingcircuitthatcanbeactivatedfor
prolonged periods by EA, lasting as long as 30–60min [41].
Inaddition,preliminarydatafromourlaboratoryusingreal-
time PCR demonstrate that preproenkephalin in the rVLM
is increased after completion of a single 30min application
of EA P 5-6 acupoints of rats [38]. The possibility that EA
induces the production of opioid mRNA in the brain stem
suggests that over time, EA may exert a long-lasting eﬀect by
stimulating increased production of opioid precursors.
14. Summary
Acupuncture has been shown to decrease BP in hyperten-
sive patients and in animal models of hypertension. The
mechanisms underlying the beneﬁcial eﬀects of acupunctureEvidence-Based Complementary and Alternative Medicine 7
are associated with modulation of sympathetic outﬂow and
possibly the endocrine system. Experimental studies have
shown that EA inhibits the reﬂex-induced hypertension by
modulating the activity of cardiovascular presympathetic
neurons in the rVLM. Activation of neurons in the arcuate
nucleus of the hypothalamus, vlPAG in the midbrain, and
NRP in the medulla by EA can inhibit the activity of
premotor sympathetic neurons in the rVLM. Glutamate,
acetylcholine, opioids, GABA, nociceptin, serotonin, NO,
and endocannabinoids in the brain all appear to participate
in the EA antihypertensive response (Figure 2). The central
action of EA may also aﬀect the endocrine system and lead to
a decrease in plasma renin, aldosterone, angiotensin II, nore-
pinephrine,andserotonin.Theneuroendocrinemechanisms
of acupuncture in the treatment of hypertension are not yet
fullyunderstood,andthusareworthyoffurtherinvestigation
(Figure 3).
Abbreviations
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